Worked with C-suite and an accounting firm to conduct an economic analysis, structure, and implement intercompany payments and agreements in preparation for an IPO of an innovative biotech incubator. The analysis included valuation of a unique biotech development and production facility, R&D, engineering and management services.
Dr. Gene Tien joins CRA's Transfer Pricing Practice
CRA is pleased to announce that Dr. Gene Tien has joined the company as a vice president in the Transfer Pricing Practice.